ASU’s 100th spinout company individualizes cancer treatment

Joseph Blattman, a researcher in ASU’s Biodesign Institute who is leading the spinout effort, worked with Professor Hao Yan to create the new immune cell profiling technology that identifies each patient’s unique tumor signature.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

*